RIFM increases transparency
This article was originally published in The Rose Sheet
Executive Summary
The Research Institute for Fragrance Materials is opening its Expert Panel review process to the public "in alignment with the fragrance industry's move towards greater transparency about its ingredients," says the scientific arm of the International Fragrance Association April 2. The move should "emphasize the credibility of its scientific methodology," according to the release. In an effort to enhance dialogue in the fragrance community, the organization is requesting information on fragrance materials in advance of meetings. The panel expects to next meet in early May to discuss macrocyclic lactones and lactides, macrocyclic ketones and ketones cyclopentanone and cyclopentenone. Information on the compounds will be accepted through April 16 and compiled as background to inform panel's discussion, RIFM says. Requests to personally present information at the meeting also will be considered
You may also be interested in...
In Brief
Council Video Squashes Cosmetic Rumors
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.